Hi Impact Consultants Pvt. Ltd.

hiimpact.in

We have been providing staffing solutions since 2011 and have grown our business to operate from NOIDA, Delhi-NCR with over 155+ people working for us every day. Now, Hi lmpact has become India’s’ No.1 Doctors'​ Recruitment company started by top 10 B School Management Graduates led by a management team with cumulative industry experience of around 100 plus years. We specialize in Healthcare Sector hiring with strong recruitment ability in the area of hiring of Doctors (clinical/nonclinical/para/academia),Senior Nursing Staff and Technicians and we have seen tremendous growth both in terms of turnover and client satisfaction.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

SEXTON BIOTECHNOLOGIES PARTNERS WITH BIOSPHERIX TO CREATE A FULLY-ENCLOSED, MODULAR FILL-FINISH SYSTEM WITH RAPID DEPLOYMENT

Sexton Biotechnologies | June 11, 2020

news image

Sexton Biotechnologies has announced a new collaboration with BioSpherix Medical. As a tool and technologies partners of the Cell and Gene industry, Sexton and BioSpherix both recognize the need for cost-effective and flexible automation solutions during cell and gene therapy process development. While some upstream bioprocesses have been successfully automated, the final steps of downstream bioprocess, namely Fill-Finish, are often done manually with associated risks of contamination and user e...

Read More

Medical

WUXI ATU AND WUGEN ANNOUNCE MANUFACTURING PARTNERSHIP TO EXPEDITE THE DELIVERY OF NOVEL CELL CANCER IMMUNOTHERAPIES

Wugen | June 16, 2022

news image

WuXi Advanced Therapies (WuXi ATU), a global Contract Testing, Development and Manufacturing Organization (CTDMO), and Wugen Inc., a clinical-stage biotechnology company based in St. Louis and San Diego, today announced a partnership to produce Wugen's WU-NK-101, a novel immunotherapy that harnesses the power of memory natural killer (NK) cells to treat cancers. WuXi ATU will provide manufacturing and testing services for WU-NK-101 to enable the delivery of this innovative cell therapy produ...

Read More

MedTech, Industrial Impact

ATRECA AND XENCOR LAUNCH NEW PROGRAM TO DEVELOP T CELL ENGAGING BISPECIFIC ANTIBODY

Atreca, Inc. | February 07, 2023

news image

On February 6, 2023, Atreca, Inc. (Atreca), a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics, and Xencor, Inc., a clinical-stage biopharmaceutical company that develops cytokines and engineered antibodies for the treatment of autoimmune diseases and cancer, announced, as part of their existing strategic collaboration, that they have mutually selected the first progr...

Read More

MedTech

ORACLE AND OXFORD NANOPORE TEAM UP TO IMPROVE HEALTHCARE AND SPEED DISCOVERY OF NEW MEDICAL BREAKTHROUGHS

Oracle | September 16, 2021

news image

Advances in DNA/RNA sequencing promise to revolutionize how medical communities identify, detect, and treat diseases and manage public health threats. To make this technology more accessible and increase its impact, Oracle has teamed up with Oxford Nanopore Technologies, the company behind a new generation of high-performance, rapid, scalable, and accessible sequencing technology. Oracle and Oxford Nanopore have recently begun a collaboration to jointly explore several potential n...

Read More
news image

SEXTON BIOTECHNOLOGIES PARTNERS WITH BIOSPHERIX TO CREATE A FULLY-ENCLOSED, MODULAR FILL-FINISH SYSTEM WITH RAPID DEPLOYMENT

Sexton Biotechnologies | June 11, 2020

Sexton Biotechnologies has announced a new collaboration with BioSpherix Medical. As a tool and technologies partners of the Cell and Gene industry, Sexton and BioSpherix both recognize the need for cost-effective and flexible automation solutions during cell and gene therapy process development. While some upstream bioprocesses have been successfully automated, the final steps of downstream bioprocess, namely Fill-Finish, are often done manually with associated risks of contamination and user e...

Read More
news image

Medical

WUXI ATU AND WUGEN ANNOUNCE MANUFACTURING PARTNERSHIP TO EXPEDITE THE DELIVERY OF NOVEL CELL CANCER IMMUNOTHERAPIES

Wugen | June 16, 2022

WuXi Advanced Therapies (WuXi ATU), a global Contract Testing, Development and Manufacturing Organization (CTDMO), and Wugen Inc., a clinical-stage biotechnology company based in St. Louis and San Diego, today announced a partnership to produce Wugen's WU-NK-101, a novel immunotherapy that harnesses the power of memory natural killer (NK) cells to treat cancers. WuXi ATU will provide manufacturing and testing services for WU-NK-101 to enable the delivery of this innovative cell therapy produ...

Read More
news image

MedTech, Industrial Impact

ATRECA AND XENCOR LAUNCH NEW PROGRAM TO DEVELOP T CELL ENGAGING BISPECIFIC ANTIBODY

Atreca, Inc. | February 07, 2023

On February 6, 2023, Atreca, Inc. (Atreca), a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics, and Xencor, Inc., a clinical-stage biopharmaceutical company that develops cytokines and engineered antibodies for the treatment of autoimmune diseases and cancer, announced, as part of their existing strategic collaboration, that they have mutually selected the first progr...

Read More
news image

MedTech

ORACLE AND OXFORD NANOPORE TEAM UP TO IMPROVE HEALTHCARE AND SPEED DISCOVERY OF NEW MEDICAL BREAKTHROUGHS

Oracle | September 16, 2021

Advances in DNA/RNA sequencing promise to revolutionize how medical communities identify, detect, and treat diseases and manage public health threats. To make this technology more accessible and increase its impact, Oracle has teamed up with Oxford Nanopore Technologies, the company behind a new generation of high-performance, rapid, scalable, and accessible sequencing technology. Oracle and Oxford Nanopore have recently begun a collaboration to jointly explore several potential n...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us